$4.00
0.071.78%
Últ. Act.: Nov 20, 3:12 PM

Atea Pharmaceuticals (AVIR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 9, 2026 | $-0.40 | $-0.50 | 20.0 % |
| Q2 | Aug 12, 2026 | $-0.41 | $-0.56 | 26.8 % |
| Q1 | May 12, 2026 | $-0.57 | $-0.56 | -1.79 % |
| Q4 | Mar 5, 2026 | $-0.57 | $-0.48 | -18.8 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q1 | May 10, 2022 | $0 | $3.33M | -100.0 % |
| Q4 | Feb 28, 2022 | $192.18M | $85.73M | 124.2 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.50 | $-0.56 | $-0.56 | $-0.48 |
| Actual | $-0.40 | $-0.41 | $-0.57 | $-0.57 |
| Surprise | +20.0% | +26.8% | -1.79% | -18.8% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.44 | $-0.38 | $-0.41 | $-0.41 |
| Revenue | ||||
| Consensus | — | — | — | — |